脂肪细胞谷氨酰胺合成酶抑制结肠癌细胞的肝、肺转移

李一飞; 陈晓珍; 张璇; 缪洪明; 梁后杰

doi:10.16016/j.1000-5404.201707147

您当前的位置：

首页 >

文章列表页 >

脂肪细胞谷氨酰胺合成酶抑制结肠癌细胞的肝、肺转移

基础医学 | 更新时间：2026-01-09

- 脂肪细胞谷氨酰胺合成酶抑制结肠癌细胞的肝、肺转移
- Glutamine synthetase from adipocytes inhibits hepatic and pulmonary metastasis of colon cancer cells
- 第三军医大学学报 2017年39卷第23期页码：2255-2262
- 作者机构：
  
  400038 重庆，第三军医大学西南医院肿瘤科
- 作者简介：
  
  [缪洪明，E-mail:hongmingmiao@sina.com MIAO Hongming, E-mail: hongmingmiao@sina.com
  [梁后杰，E-mail:lianghoujie@sina.com LIANG Houjie, E-mail: lianghoujie@sina.com
- 基金信息：
  
  国家自然科学基金青年科学基金(81702929)
- DOI：10.16016/j.1000-5404.201707147
  中图分类号： R345;R73-37;R735.35
- 收稿：2017-07-21，
  
  修回：2017-09-25，
  
  纸质出版：2017-12-15
- 稿件说明：
移动端阅览
李一飞, 陈晓珍, 张璇, 等. 脂肪细胞谷氨酰胺合成酶抑制结肠癌细胞的肝、肺转移[J]. 第三军医大学学报, 2017,39(23):2255-2262.

Yifei LI, Xiaozhen CHEN, Xuan ZHANG, et al. Glutamine synthetase from adipocytes inhibits hepatic and pulmonary metastasis of colon cancer cells[J]. Journal of Third Military Medical University, 2017, 39(23): 2255-2262.
李一飞, 陈晓珍, 张璇, 等. 脂肪细胞谷氨酰胺合成酶抑制结肠癌细胞的肝、肺转移[J]. 第三军医大学学报, 2017,39(23):2255-2262. DOI： 10.16016/j.1000-5404.201707147.

Yifei LI, Xiaozhen CHEN, Xuan ZHANG, et al. Glutamine synthetase from adipocytes inhibits hepatic and pulmonary metastasis of colon cancer cells[J]. Journal of Third Military Medical University, 2017, 39(23): 2255-2262. DOI： 10.16016/j.1000-5404.201707147.

摘要

目的

探讨脂肪细胞谷氨酰胺合成酶(glutamine synthetase，GS)对结肠癌细胞迁移及转移的调控作用。

方法

分别用野生型(WT)小鼠和脂肪细胞GS转基因(Tg

)小鼠的脂肪细胞条件培养基处理结肠癌MC38及CT26细胞，采用CCK-8法检测细胞增殖活力，流式细胞仪检测细胞凋亡，划痕实验和Transwell实验检测细胞迁移能力；通过尾静脉注射结肠癌MC38细胞建立肿瘤血行转移小鼠模型，病理切片观察肝、肺组织的转移情况。

结果

CCK-8检测发现脂肪细胞条件培养基对结肠癌MC38及CT26细胞的增殖无明显影响(

0.05)；流式细胞仪检测发现脂肪细胞条件培养基对结肠癌MC38及CT26细胞的凋亡无明显影响(

0.05)；划痕实验和Transwell实验结果显示Tg

小鼠脂肪细胞条件培养基可以抑制结肠癌MC38及CT26细胞的迁移能力(

0.05)；尾静脉注射结肠癌MC38细胞后，与WT小鼠比较，Tg

小鼠肺转移瘤的大小及数量明显减少(

0.01)，且Tg

小鼠较WT小鼠更不易发生肝转移(

0.01)。

结论

脂肪细胞GS可以抑制结肠癌细胞的迁移及转移。

Abstract

Objective

To investigate the modulation effect of glutamine synthetase (GS) from adipocytes on migration and metastasis of colon cancer cells.

Methods

The MC38 and CT26 colon cancer cells were treated with adipocyte conditional media from wild-type mice and transgenetic mice (Tg

) respectively. CCK-8 assay was used to detect the proliferation of the treated MC38 and CT26 cells. Flow cytometry was adopted to measure the apoptosis of the treated MC38 and CT26 cells. Cell scratch assay and Transwell chamber test was employed to detect the migration of the treated MC38 and CT26 cells. Then the MC38 xenograft model was established by tail vein injection in wild-type mice and Tg

transgenetic mice respectively

HE staining was used to observe the migration and invasion of xenograft.

Results

CCK-8 assay found that the 2 kinds of adipocyte conditional media barely influenced the proliferation of the MC38 and CT26 cells (

0.05). The results of flow cytometry showed that the 2 kinds of adipocyte conditional media had no effect on the apoptosis of 2 kinds of cells (

0.05). Cell scratch assay and Transwell chamber test illustrated that GS conditional media inhibited the migration of the MC38 and CT26 cells (

0.05).

In vivo

test

there were less and smaller pulmonary xenografts in the transgenetic mice than the wild-type mice after tail vein injection of MC38 cells (

0.01). And liver metastases were more common in the wild-type mice than the transgenetic mice (

0.01).

Conclusions

GS from adipocytes can inhibit migration and metastasis of colon cancer cells.

关键词

Keywords

references

JEMAL A, BRAY F, CENTER M M, et al . Global cancer statistics[J ] . CA-Cancer J Clin, 2011, 61(2): 69-90.DOI:10.3322/caac.20107.

FANG L, LU W, CHOI H H, et al . ERK2-dependent phosphorylation of CSN6 is critical in colorectal cancer development[J ] .Cancer Cell, 2015, 28(2): 183-197. DOI:10.1016/j.ccell.2015.07.004.

FERLAY J, SOERJOMATARAM I, DIKSHIT R, et al . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J ] . Int J Cancer, 2015, 136(5): E359-E386.DOI:10.1002/ijc.29210.

JANNE P A, MAYER R J. Chemoprevention of colorectal cancer[J]. N Engl J Med, 2000, 342(26): 1960-1968.DOI:10.1056/NEJM200006293422606.

LAURENT-PUIG P, CAYRE A, MANCEAU G, et al . Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer[J ] .J Clin Oncol, 2009, 27(35): 5924-5930. DOI: 10.1200/JCO.2008.21.6796.

GUPTA G P, MASSAGU J. Cancer metastasis: building a framework[J]. Cell, 2006, 127(4): 679-695.DOI:10.1016/j.cell.2006.11.001.

SONOSHITA M, AOKI M, FUWA H, et al . Suppressio n of colon cancer metastasis by Aes through inhibition of notch signaling[J ] .Cancer Cell, 2011, 19(1): 125-137. DOI:10.1016/j.ccr.2010.11.008.

MIAO H, OU J, PENG Y, et al . Macrophage ABHD5 promotes colorectal cancer growth by suppressing spermidine production by SRM[J ] .Nat Commun, 2016, 7:11716. DOI:10.1038/ncomms11716.

NIEMAN K M, KENNY H A, PENICKA C V, et al . Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth[J ] . Nat Med, 2011, 17(11): 1498-1503.DOI:10.1038/nm.2492.

DANG C V. Links between metabolism and cancer[J]. Genes Dev, 2012, 26(9):877-890.DOI:10.1101/gad.189365.112.

DEBERARDINIS R J, CHENG T. Q′s next: the diverse functions of glutamine in metabolism, cell biology and cancer[J].Oncogene, 2010, 29(3):313-324. DOI:10.1038/onc.2009.358.

HENSLEY C T, WASTI A T, DEBERARDINIS R J. Glutamine and cancer: cell biology, physiology, and clinical opportunities[J]. J Clin Invest, 2013, 123(9): 3678-3684. DOI:10.1172/JCI69600.

WISE D R, THOMPSON C B. Glutamine addiction: a new therapeutic target in cancer[J]. Trends Biochem Sci, 2010, 35(8): 427-433.DOI:10.1016/j.tibs.2010.05.003.

BOTT A J, PENG I, FAN Y, et al . Oncogenic Myc induces expression of glutamine synthetase through promoter demethylation[J ] .Cell Metab, 2015, 22(6): 1068-1077. DOI:10.1016/j.cmet.2015.09.025.

COMMISSO C, DAVIDSON S M, SOYDANER-AZELOGLU R G, et al . Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells[J ] . Nature, 2013, 497(7451): 633-637.DOI:10.1038/nature12138.

ZHAO H, YANG L, BADDOUR J, et al . Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism[J ] . eLife, 2016, 5:e10250. DOI:10.7554/eLife.10250.

TARDITO S, OUDIN A, AHMED S U, et al . Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma[J ] . Nat Cell Biol, 2015, 17(12): 1556-1568.DOI:10.1038/ncb3272.

YANG L, ACHREJA A, YEUNG T, et al . Targeting stro mal glutamine synthetase in tumors disrupts tumor microenvironment-regulated cancer cell growth[J ] . Cell Metab, 2016, 24(5): 685-700.DOI:10.1016/j.cmet.2016.10.011.

DEBERARDINIS R J, LUM J J, HATZIVASSILIOU G, et al . The biology of cancer: metabolic reprogramming fuels cell growth and proliferation[J ] . Cell Metab, 2008, 7(1): 11-20.DOI:10.1016/j.cmet.2007.10.002.

VAN DER VOS K E, ELIASSON P, PROIKAS-CEZANNE T, et al . Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy[J ] . Nat Cell Biol, 2012, 14(8): 829-837.DOI:10.1038/ncb2536.

JENKINS B J. Multifaceted role of IRAK-M in the promotion of colon carcinogenesis via barrier dysfunction and STAT3 oncoprotein stabilization in tumors[J ] . Cancer Cell, 2016, 29(5): 615-617.DOI:10.1016/j.ccell.2016.04.008.

CHRISTOFORI G. Metastatic colon cancer cells negotiate the intravasation notch[J]. Cancer Cell, 2011, 19(1): 6-8.DOI:10.1016/j.ccr.2011.01.003.

WANG J B, ERICKSON J W, FUJI R, et al . Targeting mitochondrial glutaminase activity inhibits oncogenic transformation[J ] . Cancer C ell, 2010, 18(3): 207-219. DOI:10.1016/j.ccr.2010.08.009.

PALMIERI E M, MENGA A, MART N-P REZ R, et al . Pharmacologic or genetic targeting of glutamine synthetase skews macrophages toward an M1-like phenotype and inhibits tumor metastasis[J ] .Cell Rep, 2017, 20(7):1654-1666. DOI:10.1016/j.celrep.2017.07.054.

VALENCIA T, KIM J Y, ABU-BAKER S, et al . Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis[J ] . Cancer Cell, 2014, 26(1): 121-135.DOI:10.1016/j.ccr.2014.05.004.

ROODHART J M, DAENEN L G, STIGTER E C, et al . Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids[J ] . Cancer Cell, 2011, 20(3): 370-383.DOI:10.1016/j.ccr.2011.08.010.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

低氧促进尿源性干细胞迁移与融合能力的作用研究

细胞外基质蛋白1在结直肠癌中的表达和临床意义

Stathmin通过促进伪足形成介导TNF-α诱导的皮肤成纤维细胞迁移

骨髓间充质干细胞外泌体调控肾癌细胞胆固醇代谢及其增殖、侵袭和迁移

下调METTL3-LYN m6A -IGF2BP2通路抑制内皮细胞迁移